Increased activity of plasma FXII, FXI, or kallikrein has been associated with atherosclerosis [27] and myocardial infarction [28,29], whereas severe FXI deficiency has been associated with reduced risk of stroke and deep vein thrombosis [30,31]. This evidence concerns the gene F11 and Stroke.